| Primary |
| Benign Prostatic Hyperplasia |
44.4% |
| Alopecia |
11.8% |
| Prostate Cancer |
8.9% |
| Prostatomegaly |
6.1% |
| Hypertension |
5.4% |
| Dressler's Syndrome |
2.6% |
| Prostatic Disorder |
2.5% |
| Androgenetic Alopecia |
2.3% |
| Parkinson's Disease |
2.3% |
| Prostate Examination Abnormal |
2.1% |
| Hypercholesterolaemia |
2.0% |
| Dysuria |
1.6% |
| Asthma |
1.5% |
| Prophylaxis |
1.3% |
| Inguinal Hernia Repair |
1.1% |
| Glaucoma |
0.8% |
| Hyperuricaemia |
0.8% |
| Prostatic Adenoma |
0.8% |
| Prostatic Specific Antigen Increased |
0.8% |
| Thrombosis Prophylaxis |
0.8% |
|
| Prostate Cancer |
14.4% |
| Wrong Technique In Drug Usage Process |
11.7% |
| Gynaecomastia |
10.8% |
| Breast Cancer |
8.6% |
| Drug Exposure During Pregnancy |
5.9% |
| Sexual Dysfunction |
5.4% |
| Transmission Of Drug Via Semen |
4.5% |
| Libido Decreased |
4.1% |
| Urticaria |
4.1% |
| Breast Cancer Male |
3.2% |
| Floppy Iris Syndrome |
3.2% |
| Overdose |
3.2% |
| Paternal Drugs Affecting Foetus |
3.2% |
| Semen Volume Decreased |
3.2% |
| Erectile Dysfunction |
2.7% |
| Limb Deformity |
2.7% |
| Rash |
2.7% |
| Hypospadias |
2.3% |
| Loss Of Libido |
2.3% |
| Off Label Use |
2.3% |
|
| Secondary |
| Alopecia |
19.7% |
| Androgenetic Alopecia |
18.5% |
| Benign Prostatic Hyperplasia |
14.1% |
| Product Used For Unknown Indication |
13.5% |
| Drug Use For Unknown Indication |
7.1% |
| Diabetes Mellitus |
3.1% |
| Seborrhoeic Dermatitis |
3.0% |
| Cardiac Disorder |
2.9% |
| Back Pain |
2.3% |
| Multiple Myeloma |
2.2% |
| Hypertension |
2.1% |
| Dysuria |
1.8% |
| Abnormal Sensation In Eye |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Prostate Cancer |
1.2% |
| Prostatomegaly |
1.2% |
| Prophylaxis |
1.1% |
| Prostate Examination Abnormal |
1.1% |
| Prostatitis |
1.1% |
| Hypercholesterolaemia |
1.0% |
|
| Sexual Dysfunction |
29.5% |
| Wrong Technique In Drug Usage Process |
9.3% |
| Prostate Cancer |
6.0% |
| Vomiting |
6.0% |
| Varicella |
5.5% |
| Heart Valve Incompetence |
4.9% |
| Loss Of Consciousness |
4.9% |
| Rash |
3.8% |
| Otitis Media |
3.3% |
| Urticaria |
3.3% |
| Erectile Dysfunction |
2.7% |
| Libido Decreased |
2.7% |
| Semen Volume Decreased |
2.7% |
| Drug Exposure During Pregnancy |
2.2% |
| Nausea |
2.2% |
| Pollakiuria |
2.2% |
| Prostate Cancer Stage 0 |
2.2% |
| Rash Maculo-papular |
2.2% |
| Somnolence |
2.2% |
| Thrombocytopenia |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.8% |
| Drug Use For Unknown Indication |
16.8% |
| Hypertension |
8.9% |
| Benign Prostatic Hyperplasia |
7.7% |
| Prostate Cancer |
4.7% |
| Atrial Fibrillation |
3.7% |
| Pain |
3.3% |
| Prophylaxis |
3.3% |
| Multiple Myeloma |
3.2% |
| Blood Cholesterol Increased |
3.1% |
| Diabetes Mellitus |
3.0% |
| Osteoporosis |
2.4% |
| Depression |
2.2% |
| Prostatomegaly |
2.2% |
| Type 2 Diabetes Mellitus |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Prostatic Disorder |
1.8% |
| Back Pain |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Rheumatoid Arthritis |
1.5% |
|
| Weight Decreased |
12.7% |
| Drug Ineffective |
9.8% |
| Weight Increased |
8.0% |
| Vomiting |
6.0% |
| Syncope |
4.8% |
| Renal Failure Acute |
4.5% |
| Thrombocytopenia |
4.4% |
| Urinary Tract Infection |
4.4% |
| Death |
4.2% |
| Myocardial Infarction |
4.2% |
| White Blood Cell Count Decreased |
4.1% |
| Nausea |
3.9% |
| Rash |
3.9% |
| Pain |
3.8% |
| Vision Blurred |
3.8% |
| Somnolence |
3.7% |
| Wheezing |
3.7% |
| Dyspnoea |
3.5% |
| Pneumonia |
3.4% |
| Pyrexia |
3.2% |
|
